General Information
Version
2.0
Revision date
2012-01-17
Product name
Famotidine
Product name
Famotidine
Identification on the label/Trade name
Not applicable
Chemical name
Not determined
1.2.1 Relevant identified uses
Pharmaceutical active
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Ltd
Section 2
SECTION 2: Hazards identification
Appearance White to pale yellow crystalline powder Classification of the Substance or Mixture GHS - Classification Not classified as hazardous EU Classification EU Indication of danger Not classified
Other hazards
Short Term Not acutely toxic (based on animal data) . Known Clinical Effects Adverse effects seen in clinical use include gastrointestinal discomfort, dizziness, and headache. Occasional, transient changes reported in liver function tests, but no liver damage seen. Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. Secreted in human breast milk. Australian Hazard Classification (NOHSC) Non-Hazardous Substance. Non-Dangerous Goods. Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. ‘Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
Not classified as hazardous EU Classification: EU Indication of danger: Not classified
